These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28549802)

  • 1. Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2.
    Lao K; Sun J; Wang C; Lyu W; Zhou B; Zhao R; Xu Q; You Q; Xiang H
    Steroids; 2017 Aug; 124():29-34. PubMed ID: 28549802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitors.
    Baston E; Salem OI; Hartmann RW
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):303-20. PubMed ID: 12683747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Xun G; Gou X; Xiang H
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1597-1606. PubMed ID: 31469015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.
    Aggarwal S; Thareja S; Bhardwaj TR; Haupenthal J; Hartmann RW; Kumar M
    Eur J Med Chem; 2012 Aug; 54():728-39. PubMed ID: 22776417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1.
    Arellano Y; Bratoeff E; Heuze Y; Bravo M; Soriano J; Cabeza M
    Bioorg Med Chem; 2018 Aug; 26(14):4058-4064. PubMed ID: 30007568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dehydroepiandrosterone benzimidazolyl derivatives as 5α-reductase isozymes inhibitors.
    Arellano Y; Bratoeff E; Segura T; Mendoza ME; Sánchez-Márquez A; Medina Y; Heuze Y; Soriano J; Cabeza M
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):908-14. PubMed ID: 26394987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
    Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
    Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
    Buonocore D; Verri M; Cattaneo L; Arnica S; Ghitti M; Dossena M
    Arch Ital Urol Androl; 2018 Sep; 90(3):199-202. PubMed ID: 30362688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors.
    Bratoeff E; Sánchez A; Arellano Y; Heuze Y; Soriano J; Cabeza M
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1247-54. PubMed ID: 23051174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors.
    Arellano Y; Bratoeff E; Garrido M; Soriano J; Heuze Y; Cabeza M
    Steroids; 2011 Nov; 76(12):1241-6. PubMed ID: 21729714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
    Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
    Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
    Aggarwal S; Mahapatra MK; Kumar R; Bhardwaj TR; Hartmann RW; Haupenthal J; Kumar M
    Bioorg Med Chem; 2016 Feb; 24(4):779-88. PubMed ID: 26780831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2.
    Picard F; Baston E; Reichert W; Hartmann RW
    Bioorg Med Chem; 2000 Jun; 8(6):1479-87. PubMed ID: 10896124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biochemical evaluation of (carbamoylalkenyl)phenyloxy carboxylic acid derivatives as non-steroidal 5 alpha-reductase inhibitors.
    Kattner L; Göhring S; Hartmann RW
    Arch Pharm (Weinheim); 1995 Mar; 328(3):239-45. PubMed ID: 7539251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
    Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies.
    Dhingra R; Malhotra M; Sharma V; Bhardwaj TR; Dhingra N
    Curr Top Med Chem; 2018; 18(32):2816-2834. PubMed ID: 30659542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia.
    Sun J; Xiang H; Yang LL; Chen JB
    Curr Med Chem; 2011; 18(23):3576-89. PubMed ID: 21756226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.